BamSEC and AlphaSense Join Forces
Learn More

Passage Bio Inc.

NASDAQ: PASG    
Share price (12/20/24): $0.66    
Market cap (12/20/24): $40.8 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.6
from 10-Q 55 pages Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material and Is the Type That Passage Bio, Inc. Treats as Private or Confidential. Second Amended and Restated Research, Collaboration & License Agreement Dated as of July 31, 2024 by and Between the Trustees of the University of Pennsylvania and Passage Bio, Inc
12/34/56
EX-10.5
from 10-Q 65 pages ​ ​ ​ Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material and Is the Type That Passage Bio, Inc. Treats as Private or Confidential
12/34/56
EX-10.4
from 10-Q 20 pages ​ ​ Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material and Is the Type That Passage Bio, Inc. Treats as Private or Confidential
12/34/56
EX-10.3
from 10-Q 59 pages Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material and Is the Type That Passage Bio, Inc. Treats as Private or Confidential
12/34/56
EX-10.2
from 10-Q 59 pages Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material and Is the Type That Passage Bio, Inc. Treats as Private or Confidential
12/34/56
EX-10.1
from 10-Q 60 pages Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material and Is the Type That Passage Bio, Inc. Treats as Private or Confidential
12/34/56
EX-10.1
from 10-Q 4 pages Passage Bio, Inc. Non-Employee Director Compensation Policy (Effective as of April 4, 2024) ​
12/34/56
EX-10.28
from 10-K 11 pages Employment Agreement
12/34/56
EX-10.27
from 10-K 12 pages Employment Agreement
12/34/56
EX-10.26
from 10-K 70 pages ​ Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material and Would Likely Cause Competitive Harm to Passage Bio, Inc. if Publicly Disclosed
12/34/56
EX-10.2
from 10-Q 9 pages Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material
12/34/56
EX-10.1
from 10-Q 10 pages Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material ​
12/34/56
EX-10.2
from 10-Q 4 pages Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential
12/34/56
EX-10.1
from 10-Q 3 pages Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential
12/34/56
EX-10.26
from 10-K 5 pages Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material ​
12/34/56
EX-10.24
from 10-K 14 pages Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material ​ Employment Agreement
12/34/56
EX-10.1
from 10-Q 14 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 6 pages ​ Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material and Would Likely Cause Competitive Harm to Passage Bio, Inc. if Publicly Disclosed. ​ Amendment No. 8 to Amended and Restated Research, Collaboration and License Agreement
12/34/56
EX-10.1
from 10-Q 12 pages ​ Certain Confidential Information Contained in This Document, Marked by [*], Has Been Omitted Because It Is Not Material
12/34/56
EX-10.23
from 10-K 11 pages October 30, 2021 ​
12/34/56